Tumor virology

Tumor virology manages the precise contamination and malignancy, oncogenes, tumor silencers, oncogenic cofactors, interruption of natural/flexible insusceptible reactions, idleness, viral mimicry/robbery of cellular administrative traits, genomic unsteadiness and job of non-coding RNAs in viral pathogenesis. The motive for this exam is to create viral vectors for human disease fine remedy and to develop antibody structures for therapy of viral-associated tumors. A few strategies are being accompanied incorporating hereditary vaccination with recombinant viral vectors dependent on Semliki wooded area contamination, resistant checkpoint inhibitors and processes to re-alter the immunosuppressive tumor weather.

    Related Conference of Tumor virology

    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    44th Euro Congress on Cancer Science & Therapy

    Paris, France
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK

    Tumor virology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in